Literature DB >> 3425776

Study on nonspecific immunity in pregnant women: increased chemiluminescence response of peripheral blood phagocytes.

T Shibuya1, K Izuchi, A Kuroiwa, N Okabe, K Shirakawa.   

Abstract

The total number of circulating leucocytes in the peripheral blood of pregnant women progressively increased with advance in gestation because of neutrophilia. When the phagocytic activity, representing nonspecific immunity, was estimated by a luminol-dependent chemiluminescence (CL) response during phagocytosing opsonized zymosan, we observed that the CL response of whole blood and Ficoll-Paque separated polymorphonuclear leucocytes (PMNL) significantly increased throughout the pregnancy (P less than 0.01). The CL responses of mononuclear leucocytes (MN) and monocytes also increased and reached peak levels in the third trimester (P less than 0.05). These findings suggest that the phagocytic activity in pregnant women increases, not only with regard to the number of phagocytes but also with regard to individual cell function, from a relatively early stage of the pregnancy, and that this increased nonspecific immunity may compensate in part for a weakened specific immunity of the maternal host. Attention should be directed to effects of human chorionic gonadotropin (hCG) relative to the increased CL response during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3425776     DOI: 10.1111/j.1600-0897.1987.tb00144.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol Microbiol        ISSN: 8755-8920


  9 in total

1.  Monocytes are primed to produce the Th1 type cytokine IL-12 in normal human pregnancy: an intracellular flow cytometric analysis of peripheral blood mononuclear cells.

Authors:  G P Sacks; C W G Redman; I L Sargent
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

Review 2.  Photon emission of phagocytes in relation to stress and disease.

Authors:  E M Lilius; P Marnila
Journal:  Experientia       Date:  1992-12-01

Review 3.  The role of pregnancy in the course and aetiology of rheumatoid arthritis.

Authors:  J A Da Silva; T D Spector
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

Review 4.  Postpartum group a Streptococcus sepsis and maternal immunology.

Authors:  Katie L Mason; David M Aronoff
Journal:  Am J Reprod Immunol       Date:  2011-10-24       Impact factor: 3.886

5.  Pregnancy-specific transcriptional changes upon endotoxin exposure in mice.

Authors:  Kenichiro Motomura; Roberto Romero; Adi L Tarca; Jose Galaz; Gaurav Bhatti; Bogdan Done; Marcia Arenas-Hernandez; Dustyn Levenson; Rebecca Slutsky; Chaur-Dong Hsu; Nardhy Gomez-Lopez
Journal:  J Perinat Med       Date:  2020-09-25       Impact factor: 1.901

6.  Pregnancy and preeclampsia affect monocyte subsets in humans and rats.

Authors:  Barbro N Melgert; Floor Spaans; Theo Borghuis; Pieter A Klok; Bart Groen; Annemarie Bolt; Paul de Vos; Maria G van Pampus; Tsz Y Wong; Harry van Goor; Winston W Bakker; Marijke M Faas
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

7.  Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study.

Authors:  Thomas A Kraus; Stephanie M Engel; Rhoda S Sperling; Lisa Kellerman; Yungtai Lo; Sylvan Wallenstein; Maria M Escribese; Jose L Garrido; Tricia Singh; Martine Loubeau; Thomas M Moran
Journal:  J Clin Immunol       Date:  2011-12-24       Impact factor: 8.317

8.  The Cellular Transcriptome in the Maternal Circulation During Normal Pregnancy: A Longitudinal Study.

Authors:  Nardhy Gomez-Lopez; Roberto Romero; Sonia S Hassan; Gaurav Bhatti; Stanley M Berry; Juan Pedro Kusanovic; Percy Pacora; Adi L Tarca
Journal:  Front Immunol       Date:  2019-12-17       Impact factor: 7.561

9.  The role of CD4+CD25bright regulatory T cells in the maintenance of pregnancy, premature rupture of membranes, and labor.

Authors:  Hyun-Joo Seol; Min-Jeong Oh; Ji-Eun Lim; Nan-Hee Jung; Soo-Young Yoon; Hai-Joong Kim
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.